Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 4 art units • 4 examiners • 0 of 20 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
ThermoLife International LLC is currently facing 15 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are concentrated among 4 distinct examiners, which is a high level of examiner density for a portfolio of this size. Furthermore, the work is limited to 4 distinct art units, suggesting a focused technical scope within the Biotechnology & Pharmaceuticals sector. The fact that 15 pending office actions are handled by only 4 distinct examiners allows the company to develop a deep understanding of each examiner's specific requirements.
HAVLIN, ROBERT H is the busiest examiner for this portfolio, overseeing 6 pending office actions. This means that HAVLIN, ROBERT H alone is responsible for 6 of the 15 pending office actions, giving him significant influence over the company's prosecution outcomes. With 4 distinct art units involved, the company can focus its resources on a narrow set of procedural standards. The 6 pending office actions assigned to HAVLIN, ROBERT H represent a critical focal point, as his decisions will impact a large portion of the current pipeline. Practitioners should prioritize the preferences of the 4 distinct examiners to advance the 15 pending office actions effectively.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (25%) |
| Double-patenting + other | 13 (65%) |
| Multi-statute (no §101) | 2 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAVLIN, ROBERT H | 9 | 51.3% | +28.3% |
| PIHONAK, SARAH | 5 | 61.4% | +42.4% |
| KASSA, TIGABU | 5 | 36.7% | +27.9% |
| BOATENG, AFUA BAMFOAA | 1 | 46.7% | +64.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19556587 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | — |
| 18791306 | PERCARBONATE COMPOSITIONS AND USES THEREOF | BOATENG, AFUA BAMFOAA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18399465 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 18399677 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 18399664 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 18399668 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 19562667 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559811 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559613 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559822 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| Art Unit | Apps |
|---|---|
| 1626 | 9 |
| 1627 | 5 |
| 1619 | 5 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19562667 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 10, 2026 |
| 19559811 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559613 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559822 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559360 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559196 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559247 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559853 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559685 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19556454 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556587 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112Other | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556505 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556470 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556549 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 18791306 | PERCARBONATE COMPOSITIONS AND USES THEREOF | BOATENG, AFUA BAMFOAA | 1617 | §102§103 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18399465 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 18399677 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 18399664 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 18399668 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 16779349 | Enhanced Nitrate Compositions and Methods of Use | KASSA, TIGABU | 1619 | §103 | Final Rejection | — | Pending | Jan 31, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThermoLife International LLC has 20 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Robert H Havlin has the most, with 9 of ThermoLife International LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
